Benzinga - Mon, 01 Mar 2021 05:56:51 -0400
Benzinga - Fri, 26 Feb 2021 13:46:24 -0400
Benzinga - Fri, 26 Feb 2021 13:09:02 -0400
Benzinga - Fri, 26 Feb 2021 09:08:04 -0400
Benzinga - Fri, 26 Feb 2021 05:52:14 -0400
Benzinga - Thu, 25 Feb 2021 11:03:18 -0400
Benzinga - Tue, 29 Dec 2020 09:12:15 -0400
Benzinga - Thu, 17 Dec 2020 06:00:33 -0400
load more
Recro Pharma Inc is a contract development and manufacturing company. The company is engaged in the development, formulation, regulatory support, manufacturing, and packaging of oral solid dose drug products. Its product portfolio includes Ritalin LA, Focalin XR, Verelan PM, SR & Verapamil PM, Verapamil SR, and Zohydro ER.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-10
REV
Q4 2020Est.ActualSurprise
EPS-0.250-0.480 -0.2300
REV15.000M9.913M-5.087M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
REPHRecro Pharma0%91.5M

Recro Pharma Company Questions & Answers

Q

How do I buy Recro Pharma (REPH) stock?

A

You can purchase shares of Recro Pharma (NASDAQ: REPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Recro Pharma's (REPH) main competitors?

A

There are no as such competitors for Recro Pharma.

Q

What is the target price for Recro Pharma?

A

The latest price target for Recro Pharma (NASDAQ: REPH) was reported by Oppenheimer on 2020-05-12. The analyst firm set a price target for 12.00 expecting REPH to rise to within 12 months (a possible 306.78% upside). 1 analyst firms have reported ratings in the last year.

Q

How much is Recro Pharma (REPH) stock ?

A

The stock price for Recro Pharma (NASDAQ: REPH) is $2.95 last updated Today at 8:00:02 PM.

Q

When is the next Recro Pharma (REPH) dividend?

A

There are no upcoming dividends for Recro Pharma.

Q

When is Recro Pharma (NASDAQ:REPH) reporting earnings?

A
Recro Pharma’s Q1 earnings are confirmed from now on May 10, 2021.
Q

When is the upcoming split for REPH?

A

There is no upcoming split for Recro Pharma.